Empowering mental health professionals with peer-reviewed psychiatric research and insights

Just Published

Review Articles

JCP
Treating PTSD in Military Populations
JCP
Changes in Cognition in Patients With Schizophrenia
JCP
Economic Impact of Cognitive Impairment and Negative Symptoms in Schizophrenia
JCP
Cognitive Effects of ECT in Schizophrenia: A Review
JCP
Interpersonal Psychotherapy for PTSD: A Critical Review
JCP
Omega-3 PUFA Supplements for ADHD

Read articles from ASCP Corner

ASCP Corner

Letters to the Editor

JCP
Misleading Labeling of S-Methadone as a Novel N-Methyl-D-Aspartate Receptor Antagonist
JCP
Reasons for Maintaining the Classification of Esmethadone as an Investigational Uncompetitive NMDAR Antagonist Rapid Antidepressant: Reply to Ferré and Michaelides
JCP
Psychedelic Therapies: One Drug, Multiple Treatments: Reply to Modesto-Lowe et al
JCP
Toward Consensus in Psychedelic-Assisted Therapy: The Critical Role of Psychotherapeutic Support
JCP
Suicide Risk among Patients with Bipolar Disorder: Sleep Disruption versus Benzodiazepine Use
JCP
Erecting Barriers to Suicide by Removing Barriers to Science

Commentaries

JCP
How Do We Get Ketamine Safety Right? Three Questions from a Clinical Service
JCP
Lower Risk of Cardiovascular Disorders in Antidepressant-Treated Women Veterans: Encouraging Findings but Concerns Remain
JCP
Benefits and Risks of New Tests for Alzheimer’s Disease
JCP
Investigation of Appetite Hormones Illustrates Current Limitations of Psychiatric Diagnosis
JCP
Eating Disorders Among Transgender and Gender Diverse People: Qualitative Analysis of Reddit Threads
JCP
A New Tool to Refine Lithium Therapy: Simple Formula for a Complex Problem

More JCP Articles

JCP
Nonmedical Use and Substance Use Disorder Symptoms in US Adults Co-Prescribed Opioids and Benzodiazepines
JCP
Comparing the Cognitive Effects of Repeated IV Ketamine and ECT in Patients with Treatment-Resistant Depression: A Secondary Analysis of the ELEKT-D Trial
JCP
Five-Year Outcomes of First Suicide Attempts: Lethality, Recurrence, and Mortality
JCP
Artificial Intelligence in Depression – Medication Enhancement (AID-ME): A Cluster Randomized Trial of a Clinical Decision Support System for Personalized Depression Treatment Selection and Management
JCP
N-acetylcysteine for Co-occurring PTSD and Alcohol Use Disorder: A Double-Blind, Randomized Controlled Trial
JCP
Lumateperone as Adjunctive Therapy in MDD: A Randomized, Double-Blind, Phase 3 Trial
JCP
Levomilnacipran, but Not Duloxetine, Inhibits Serotonin and Norepinephrine Reuptake Throughout Its Therapeutic Range
JCP
The Superiority of Clozapine Over SGAs in Patients With Treatment-Resistant Schizophrenia
JCP
In Memoriam: Terence A. Ketter, MD
JCP
PSI Response: FDA Panel Discussion Regarding SSRIs in Pregnancy
JCP
Clinical Application of Aripiprazole Monohydrate Long-Acting Injectables for the Treatment of Bipolar Type I Disorder: A Consensus Panel Report
JCP
Clinical Application of Aripiprazole Monohydrate Long-Acting Injectables for the Treatment of Schizophrenia: A Consensus Panel Report